Power Law company profile

Elite Pharmaceuticals

Biotech & Life Sciences · Northvale, United States · Founded 1996 · IPO 2003 Colt

Specialty pharmaceutical company developing abuse deterrent opioids and niche generics to curb misuse and abuse

Valuation

$353M

Market cap · May/2026

Revenue

$84M

Latest reported FY

EBITDA

$23M

Latest reported FY

Featured in $1B+ revenueColt · Power Law growth-stage

Global footprint

Where Elite Pharmaceuticals has talent and traffic

Workforce by country

🇺🇸 United States · Northvale HQ

Book a demo for the full country breakdown

Web traffic by country

3.2K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Market sentiment

What the market is saying about Elite Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Elite Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Elite Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles